<DOC>
	<DOCNO>NCT00330447</DOCNO>
	<brief_summary>The researcher aim investigate outcome ( overall survival ) mother diagnose and/or treated cancer pregnancy . Furthermore want test hypothesis child expose cytotoxic drug utero , radiotherapy , develop normally ( neurologic cardiologic examination ) .</brief_summary>
	<brief_title>Effects Oncological Treatment During Pregnancy</brief_title>
	<detailed_description>Prospectively outcome mother diagnose and/or treated cancer pregnancy register investigated . In prospective trial invite child expose cytotoxic drug radiotherapy utero standardized neurological cardiological examination . The examination do qualified psychologist , neurological cardiological pediatrician .</detailed_description>
	<criteria>Patients must meet follow inclusion criterion : Histologically proven cancer pregnancy Patients must adequate bone marrow , renal , hepatic pulmonary function . World Health Organization ( WHO ) performance status 0 1 &gt; 18 year age Patients give sign write informed consent participate trial fully understanding implication protocol Women receive cytotoxic drug pregnancy allow assessment maternal fetal outcome Patients allow opt pharmacokinetic part clinical followup part study need participate ; however , preferentially study part perform . Women receive kind radiotherapy pregnancy Mentally disable significantly alter mental status would prohibit understanding give informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>pregnancy</keyword>
	<keyword>utero</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>cancer</keyword>
	<keyword>offspring</keyword>
	<keyword>neonatal</keyword>
	<keyword>long term</keyword>
	<keyword>follow</keyword>
	<keyword>cancer pregnancy</keyword>
	<keyword>chemotherapy radiotherapy pregnancy</keyword>
	<keyword>long term follow child</keyword>
</DOC>